Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Upstream Bioprocessing Market - Global Size, Trends, and Forecast 2026-2032 | Biologics Demand, AI, and Single-Use Systems Propel 15.21% CAGR and a USD 66.73 Billion Opportunity

globenewswire.com
AVTR Avantor Inc is mentioned as a company in the competitive landscape of the upstream bioprocessing market. The article does not provide specific sentiment towards the company's performance or prospects. GLW Corning Incorporated is listed as a company within the upstream bioprocessing market's competitive landscape. The article does not offer any specific sentiment or details about the company's performance. AMZN While not explicitly mentioned, Amazon is a major player in cloud computing and AI infrastructure, which are indirectly relevant to the AI and digital process control aspects of the upstream bioprocessing market discussed in the article. However, no direct mention or sentiment is provided. MSFT Microsoft's AI and cloud services are relevant to the 'Artificial Intelligence and Digital Process Control' section of the report. However, the article does not explicitly mention Microsoft or provide any sentiment towards its involvement in this market. GOOG Alphabet (Google) is a leader in AI, which is a key driver in the upstream bioprocessing market as mentioned in the article. However, the article does not explicitly name Alphabet or provide any specific sentiment towards its role. IBM IBM's AI and data analytics capabilities are relevant to the 'Artificial Intelligence and Digital Process Control' theme. However, the article does not explicitly mention IBM or provide any sentiment regarding its position in this market. TMO Thermo Fisher Scientific Inc is mentioned as a company in the competitive landscape of the upstream bioprocessing market. The article does not provide specific sentiment towards the company's performance or prospects. DHR Danaher Corporation is listed as a company within the upstream bioprocessing market's competitive landscape. The article does not offer any specific sentiment or details about the company's performance. AMGN Amgen Inc. is a biopharmaceutical company that would be a user of upstream bioprocessing technologies. The article discusses the demand for biologics, which Amgen produces, but does not mention the company directly or provide specific sentiment. GILD Gilead Sciences, Inc. is a biopharmaceutical company involved in biologics production. The article highlights the growth in demand for biologics, but does not specifically mention Gilead or provide sentiment. BMY Bristol Myers Squibb Company is a biopharmaceutical firm that utilizes upstream bioprocessing. The article discusses market growth driven by demand for biologics, but does not name Bristol Myers Squibb or offer sentiment. REGN Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company involved in biologics. The article mentions the growing demand for biologics as a market driver, but does not specifically mention Regeneron or provide sentiment. MRK Merck & Co., Inc. is a biopharmaceutical company that would benefit from advancements in upstream bioprocessing. The article discusses market drivers like vaccines and cell/gene therapies, but does not explicitly mention Merck or provide sentiment. PFE Pfizer Inc. is a major biopharmaceutical company involved in vaccine and biologics production. The article highlights growth drivers like vaccines, but does not explicitly mention Pfizer or provide sentiment. JNJ Johnson & Johnson is a large healthcare company with biopharmaceutical operations. The article discusses market growth drivers like cell and gene therapies, but does not explicitly mention J&J or provide sentiment. ABBV AbbVie Inc. is a biopharmaceutical company focused on biologics. The article mentions growing demand for monoclonal antibodies and recombinant proteins, key areas for AbbVie, but does not name the company or provide sentiment. BIIB Biogen Inc. is a biopharmaceutical company involved in biologics and therapies. The article discusses market growth drivers like cell and gene therapies, but does not explicitly mention Biogen or provide sentiment. MDLZ Mondelez International, Inc. is not directly related to the upstream bioprocessing market described in the article. The article focuses on biotech and pharmaceuticals, not consumer packaged goods. CL Colgate-Palmolive Company operates in the consumer goods sector and is not directly related to the upstream bioprocessing market discussed in the article. PG Procter & Gamble Company is a consumer goods company and is not directly involved in the upstream bioprocessing market detailed in the article. KO The Coca-Cola Company is in the beverage industry and has no direct connection to the upstream bioprocessing market described in the article. PEP PepsiCo, Inc. operates in the food and beverage sector and is not directly relevant to the upstream bioprocessing market discussed in the article. SBUX Starbucks Corporation is a coffeehouse chain and is not related to the upstream bioprocessing market discussed in the article. MCD McDonald's Corporation is in the fast-food industry and has no direct relevance to the upstream bioprocessing market described in the article. NKE NIKE, Inc. operates in the athletic footwear and apparel industry and is not related to the upstream bioprocessing market discussed in the article. DIS The Walt Disney Company is primarily involved in entertainment and media, with no direct connection to the upstream bioprocessing market detailed in the article. HD The Home Depot, Inc. is a home improvement retailer and is not related to the upstream bioprocessing market discussed in the article. CMCSA Comcast Corporation is a media and technology company, not directly involved in the upstream bioprocessing market described in the article. VZ Verizon Communications Inc. is a telecommunications company and is not directly related to the upstream bioprocessing market discussed in the article. T AT&T Inc. is a telecommunications company and is not directly involved in the upstream bioprocessing market detailed in the article. XOM Exxon Mobil Corporation is an energy company and is not directly related to the upstream bioprocessing market discussed in the article. CVX Chevron Corporation is an energy company and is not directly involved in the upstream bioprocessing market detailed in the article. BA The Boeing Company is an aerospace company and is not related to the upstream bioprocessing market discussed in the article. CAT Caterpillar Inc. manufactures construction and mining equipment and is not directly involved in the upstream bioprocessing market detailed in the article. GE General Electric Company operates in various sectors, but its core businesses are not directly related to the upstream bioprocessing market discussed in the article. HON Honeywell International Inc. is a diversified technology and manufacturing company. While it has some healthcare-related segments, it's not directly identified as a player in the upstream bioprocessing market in this article. LMT Lockheed Martin Corporation is primarily an aerospace and defense company and is not related to the upstream bioprocessing market discussed in the article. RTX Raytheon Technologies Corporation is an aerospace and defense company and is not related to the upstream bioprocessing market discussed in the article. GD General Dynamics Corporation is a defense contractor and is not related to the upstream bioprocessing market discussed in the article. MMC Marsh & McLennan Companies, Inc. is a professional services company and is not directly involved in the upstream bioprocessing market detailed in the article. AXP American Express Company is a financial services company and is not related to the upstream bioprocessing market discussed in the article. V Visa Inc. is a payment technology company and is not directly involved in the upstream bioprocessing market detailed in the article. MA Mastercard Incorporated is a financial services company and is not directly related to the upstream bioprocessing market discussed in the article. BAC Bank of America Corporation is a financial institution and is not directly involved in the upstream bioprocessing market detailed in the article. JPM JPMorgan Chase & Co. is a financial services company and is not directly related to the upstream bioprocessing market discussed in the article. WFC Wells Fargo & Company is a financial services company and is not directly involved in the upstream bioprocessing market detailed in the article. C Citigroup Inc. is a financial services company and is not directly related to the upstream bioprocessing market discussed in the article. GS The Goldman Sachs Group, Inc. is an investment banking and financial services company and is not directly involved in the upstream bioprocessing market detailed in the article. MS Morgan Stanley is an investment banking and financial services company and is not directly related to the upstream bioprocessing market discussed in the article. NVDA NVIDIA Corporation is a key player in AI hardware, which is mentioned as a driver in the upstream bioprocessing market. However, the article does not explicitly mention NVIDIA or provide specific sentiment. AMD Advanced Micro Devices, Inc. (AMD) is involved in AI and chip design, relevant to the AI aspects of the market. However, the article does not explicitly mention AMD or provide specific sentiment. INTC Intel Corporation is a major semiconductor company. While AI is a driver for the bioprocessing market, Intel is not explicitly mentioned, and no specific sentiment is provided. QCOM Qualcomm Incorporated is a semiconductor company. While AI is a growing area, the article does not explicitly mention Qualcomm or provide specific sentiment related to its involvement in the bioprocessing market. MU Micron Technology, Inc. is a memory chip manufacturer. While memory is crucial for AI, the article does not explicitly mention Micron or provide specific sentiment regarding its role in the bioprocessing market. AMAT Applied Materials, Inc. provides manufacturing equipment for semiconductors. While semiconductors are relevant to AI, the article does not explicitly mention AMAT or provide specific sentiment. LRCX Lam Research Corporation designs and manufactures wafer fabrication equipment. While relevant to chip making, the article does not explicitly mention LRCX or provide specific sentiment. ASML ASML Holding N.V. is a key supplier of photolithography equipment for the semiconductor industry. While semiconductors are relevant to AI, ASML is not explicitly mentioned, and no specific sentiment is provided. ADI Analog Devices, Inc. designs and manufactures semiconductor devices. While AI is a driver, the article does not explicitly mention ADI or provide specific sentiment. TXN Texas Instruments Incorporated designs and manufactures semiconductors. While AI is a growing area, the article does not explicitly mention TXN or provide specific sentiment. ON ON Semiconductor Corporation provides semiconductor solutions. While AI is a driver, the article does not explicitly mention ON or provide specific sentiment. NXPI NXP Semiconductors N.V. designs and manufactures mixed-signal and standard product semiconductor components. While AI is a driver, the article does not explicitly mention NXPI or provide specific sentiment. INFY Infosys Limited is an IT services company that could provide AI solutions. However, the article does not explicitly mention Infosys or provide specific sentiment. WDC Western Digital Corporation manufactures data storage devices. While data storage is crucial for AI, the article does not explicitly mention WDC or provide specific sentiment. SE Sea Limited is a Singaporean multinational tech conglomerate. While it has AI initiatives, it's not directly mentioned in the context of the upstream bioprocessing market, and no specific sentiment is provided. CRSP CRISPR Therapeutics AG is a biotechnology company focused on gene editing. The article mentions cell and gene therapies as a driver for the bioprocessing market, but does not specifically mention CRISPR Therapeutics or provide sentiment. EDIT Editas Medicine, Inc. is a biotechnology company using CRISPR gene editing. The article mentions cell and gene therapies as market drivers, but does not specifically mention Editas Medicine or provide sentiment. BEAM Beam Therapeutics Inc. is a biotechnology company developing gene-based medicines. The article discusses cell and gene therapies as market drivers, but does not specifically mention Beam Therapeutics or provide sentiment. NTLA Intellia Therapeutics, Inc. is a biotechnology company focused on gene editing. The article mentions cell and gene therapies as market drivers, but does not specifically mention Intellia Therapeutics or provide sentiment. BNTX BioNTech SE is a biotechnology company involved in vaccine development. The article highlights vaccine production as a driver for the bioprocessing market, but does not specifically mention BioNTech or provide sentiment. MRNA Moderna, Inc. is a biotechnology company focused on mRNA therapeutics and vaccines. The article mentions vaccine production as a market driver, but does not specifically mention Moderna or provide sentiment. NVAX Novavax, Inc. is a biotechnology company developing vaccines. The article highlights vaccine production as a driver for the bioprocessing market, but does not specifically mention Novavax or provide sentiment. BABA Alibaba Group Holding Limited is a Chinese multinational technology company. While it has cloud and AI initiatives, it is not directly mentioned in the context of the upstream bioprocessing market, and no specific sentiment is provided. JD JD.com, Inc. is a Chinese e-commerce company. It is not directly related to the upstream bioprocessing market discussed in the article, and no specific sentiment is provided. BHP BHP Group Limited is a mining company and is not related to the upstream bioprocessing market discussed in the article. RIO Rio Tinto plc is a mining company and is not related to the upstream bioprocessing market discussed in the article. VALE Vale S.A. is a Brazilian mining company and is not related to the upstream bioprocessing market discussed in the article. NVS Novartis AG is a pharmaceutical company. The article discusses the biopharmaceutical market, but does not specifically mention Novartis or provide sentiment. ROG Roche Holding AG is a pharmaceutical company. The article discusses the biopharmaceutical market, but does not specifically mention Roche or provide sentiment. AZN AstraZeneca PLC is a pharmaceutical company. The article discusses the biopharmaceutical market, but does not specifically mention AstraZeneca or provide sentiment. SNY Sanofi S.A. is a pharmaceutical company. The article discusses the biopharmaceutical market, but does not specifically mention Sanofi or provide sentiment. PAR Parker Hannifin Corporation is mentioned as a company in the competitive landscape of the upstream bioprocessing market. The article does not provide specific sentiment towards the company's performance or prospects. EL Estée Lauder Companies Inc. is in the beauty industry and is not related to the upstream bioprocessing market discussed in the article. ORCL Oracle Corporation provides cloud services and enterprise software, which could support AI initiatives. However, the article does not explicitly mention Oracle or provide specific sentiment. SAP SAP SE provides enterprise software solutions, which could be used in bioprocessing. However, the article does not explicitly mention SAP or provide specific sentiment. CRM Salesforce, Inc. offers cloud-based software, including AI capabilities. However, the article does not explicitly mention Salesforce or provide specific sentiment regarding its role in bioprocessing. ADBE Adobe Inc. provides creative and digital marketing software. While it has AI components, it is not directly related to the upstream bioprocessing market described in the article. NFLX Netflix, Inc. is an entertainment streaming service and is not related to the upstream bioprocessing market discussed in the article. META Meta Platforms, Inc. is involved in social media and metaverse technologies, with AI research. However, it is not directly mentioned in the context of the upstream bioprocessing market, and no specific sentiment is provided. UBER Uber Technologies, Inc. is a ride-sharing and delivery company. It is not directly related to the upstream bioprocessing market discussed in the article, and no specific sentiment is provided. LYFT Lyft, Inc. is a ride-sharing company and is not related to the upstream bioprocessing market discussed in the article. SPGI S&P Global Inc. provides financial information and analytics. While it covers market data, it is not directly involved in the upstream bioprocessing market as a product/service provider, and no specific sentiment is provided. MDT Medtronic plc is a medical device company. While its products might be used in healthcare settings, it's not directly identified as a player in the upstream bioprocessing market in this article. ISRG Intuitive Surgical, Inc. develops robotic surgical systems. While related to healthcare, it's not directly involved in the upstream bioprocessing market described in the article. ABNB Airbnb, Inc. is a hospitality company and is not related to the upstream bioprocessing market discussed in the article. PYPL PayPal Holdings, Inc. is a financial technology company and is not directly involved in the upstream bioprocessing market detailed in the article. COIN Coinbase Global, Inc. is a cryptocurrency exchange platform. While cryptocurrency is a 'hot market', it is not related to the upstream bioprocessing market described in the article. PLTR Palantir Technologies Inc. provides data analytics and AI software. While AI is relevant, the article does not explicitly mention Palantir or provide specific sentiment. DDOG Datadog, Inc. provides monitoring and analytics for cloud applications. While it supports AI infrastructure, the article does not explicitly mention Datadog or provide specific sentiment. SNOW Snowflake Inc. offers a cloud-based data warehousing platform, crucial for AI. However, the article does not explicitly mention Snowflake or provide specific sentiment. ZS Zscaler, Inc. provides cloud security solutions. While security is important for AI infrastructure, the article does not explicitly mention Zscaler or provide specific sentiment. CRWD CrowdStrike Holdings, Inc. provides cloud workload and endpoint security. While it supports AI infrastructure, the article does not explicitly mention CrowdStrike or provide specific sentiment. PANW Palo Alto Networks, Inc. provides cybersecurity solutions. While it supports AI infrastructure, the article does not explicitly mention PANW or provide specific sentiment. FTNT Fortinet, Inc. provides broad, integrated, and automated cybersecurity solutions. While it supports AI infrastructure, the article does not explicitly mention FTNT or provide specific sentiment. GOOGL Alphabet (Google) is a leader in AI, which is a key driver in the upstream bioprocessing market as mentioned in the article. However, the article does not explicitly name Alphabet or provide any specific sentiment towards its role.

Upstream Bioprocessing Market - Global Size, Trends, and Forecast 2026-2032 | Biologics Demand, AI, and Single-Use Systems Propel 15.21% CAGR and a USD 66.73 Billion Opportunity Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Upstream Bioprocessing Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

The global upstream bioprocessing market research report provides an in-depth assessment of technologies, operating models, regional developments, and competitive priorities shaping biologics manufacturing. The market is projected to reach USD 28.42 billion in 2026 and expand at a CAGR of 15.21% to USD 66.73 billion by 2032, driven by growing demand for monoclonal antibodies, recombinant proteins, vaccines, biosimilars, and cell and gene therapies.

Market Dynamics and Industry Transformation

Upstream bioprocessing encompasses cell line development, media and feed optimization, seed-train expansion, bioreactor operations, and process monitoring before harvest. Manufacturers are shifting from capacity-led expansion toward productivity-focused operations built around high-yield expression systems, chemically defined media, closed processing, single-use bioreactors, and process analytical technology.

These insights support strategic planning by clarifying where investments in process intensification, flexible capacity, and contamination control can deliver the greatest operational value.

Artificial Intelligence and Digital Process Control

Artificial intelligence is emerging as a practical decision-support layer for design of experiments, media optimization, cell culture monitoring, anomaly detection, soft sensors, and predictive control. Relevant process parameters include pH, dissolved oxygen, temperature, viable cell density, osmolality, glucose, lactate, and metabolite profiles.

Effective AI adoption can shorten development cycles, reduce failed runs, improve batch consistency, and strengthen scale-up and deviation management. Competitive advantage depends on combining these capabilities with validated models, audit-ready data pipelines, human oversight, and GxP-compatible documentation.

Regional Market Insights

Country- and region-level comparisons provide a practical basis for evaluating market entry options, partnership opportunities, manufacturing locations, and supply-chain exposure.

Strategic Group and Competitive Insights

ASEAN is gaining relevance through Singapore's mature ecosystem and expanding pharmaceutical participation across Malaysia, Thailand, Vietnam, Indonesia, and the Philippines. The European Union offers a harmonized regulatory environment, while BRICS economies combine substantial domestic demand with growing manufacturing capabilities. G7 markets continue to influence regulatory science and advanced manufacturing standards, and NATO members increasingly emphasize biosecurity and critical-input resilience.

Strategic Priorities for Industry Leaders

These priorities enable decision-makers to mitigate development and supply risks while aligning scientific investment with regulatory readiness and commercial scale.

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Upstream Bioprocessing Market, by Product

7.1. Introduction

7.2. Accessories And Consumables

7.3. Bioreactors

7.4. Media And Reagents

7.4.1. Media

7.4.1.1. Basal Media

7.4.1.2. Chemically Defined Media

7.4.1.3. Serum-Free Media

7.4.2. Reagents

7.4.2.1. Buffers And Salts

7.4.2.2. Cell Culture Supplements

7.4.2.3. Growth Factors

7.5. Sensors And Probes

7.6. Single-Use Equipment

8. Upstream Bioprocessing Market, by Technology

8.1. Introduction

8.2. Airlift Bioreactors

8.3. Fixed-Bed Bioreactors

8.4. Single-Use Bioreactors

8.5. Stirred-Tank Bioreactors

8.6. Wave Bioreactors

9. Upstream Bioprocessing Market, by Scale

9.1. Introduction

9.2. Lab Scale

9.3. Large Scale

9.4. Pilot Scale

10. Upstream Bioprocessing Market, by Cell Type

10.1. Introduction

10.2. Insect Cell Culture

10.3. Mammalian Cell Culture

10.4. Microbial Fermentation

10.5. Plant Cell Culture

11. Upstream Bioprocessing Market, by Application

11.1. Introduction

11.2. Cell Therapy Production

11.3. Gene Therapy Vector Production

11.4. Monoclonal Antibody Production

11.5. Recombinant Protein Production

11.6. Vaccine Production

12. Upstream Bioprocessing Market, by End User

12.1. Introduction

12.2. Academic And Research Institutes

12.3. Biopharmaceutical Companies

12.4. Contract Research Organizations

12.5. Government Laboratories

13. Upstream Bioprocessing Market, by Region

13.1. Introduction

13.2. Asia-Pacific

13.3. Europe

13.4. North America

13.5. Latin America

13.6. Africa

13.7. Middle East

14. Upstream Bioprocessing Market, by Group

14.1. Introduction

14.2. NATO

14.3. G7

14.4. BRICS

14.5. European Union

14.6. ASEAN

14.7. GCC

15. Upstream Bioprocessing Market, by Country

15.1. Introduction

15.2. China

15.3. United States

15.4. Japan

15.5. India

15.6. Germany

15.7. United Kingdom

15.8. Australia

15.9. France

15.10. South Korea

15.11. Italy

15.12. Canada

15.13. Russia

15.14. Brazil

15.15. Mexico

15.16. Spain

16. Competitive Landscape

16.1. Market Share Analysis, 2025

16.2. Market Concentration Analysis, 2025

16.2.1. Concentration Ratio (CR)

16.2.2. Herfindahl Hirschman Index (HHI)

16.3. Recent Developments & Impact Analysis, 2025

16.4. Product Portfolio Analysis, 2025

16.5. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Avantor Inc

17.2. BBI-biotech GmbH

17.3. Bioengineering AG

17.4. Cellexus International Ltd

17.5. Corning Incorporated

17.6. Danaher Corporation

17.7. Distek Inc

17.8. Entegris Inc

17.9. Eppendorf SE

17.10. Esco Lifesciences Group Ltd

17.11. Fujimori Kogyo Co Ltd

17.12. Getinge AB

17.13. Kuhner AG

17.14. Lonza Group Ltd

17.15. Meissner Filtration Products Inc

17.16. Merck KGaA

17.17. OmniBRx Biotechnologies

17.18. Parker Hannifin Corporation

17.19. PBS Biotech Inc

17.20. PharmNXT Biotech

17.21. Saint-Gobain Performance Plastics

17.22. Sartorius AG

17.23. Shanghai Lepure Biotech Co Ltd

17.24. Solaris Biotech Srl

17.25. Thermo Fisher Scientific Inc

17.26. Tofflon Life Science Co Ltd

18. Key Experts

List of Figures [23]

List of Tables [362]

For more information about this report visit https://www.researchandmarkets.com/r/3491fi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.